Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Theravance Biopharma (TBPH) Asset Utilization Ratio (2016 - 2025)

Theravance Biopharma (TBPH) has disclosed Asset Utilization Ratio for 12 consecutive years, with 0.19 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio rose 6.0% to 0.19 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.19 through Dec 2025, up 6.0% year-over-year, with the annual reading at 0.26 for FY2025, 46.33% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.19 at Theravance Biopharma, up from 0.19 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.2 in Q2 2025, with the low at 0.06 in Q4 2022.
  • Average Asset Utilization Ratio over 5 years is 0.14, with a median of 0.15 recorded in 2021.
  • The sharpest move saw Asset Utilization Ratio tumbled 74.15% in 2021, then skyrocketed 143.42% in 2023.
  • Over 5 years, Asset Utilization Ratio stood at 0.14 in 2021, then crashed by 58.3% to 0.06 in 2022, then surged by 143.42% to 0.14 in 2023, then rose by 25.58% to 0.18 in 2024, then rose by 6.0% to 0.19 in 2025.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.19, 0.19, and 0.2 for Q4 2025, Q3 2025, and Q2 2025 respectively.